Home Apnea Testing in CHildren Trial
Home Sleep Apnea Testing Compared to In-lab Polysomnography for the Evaluation of Obstructive Sleep Apnea in Children
Children's Hospital of Philadelphia
317 participants
Mar 29, 2023
INTERVENTIONAL
Conditions
Summary
This clinical trial will compare home sleep apnea testing with the gold standard in-lab polysomnography in terms of 1) accuracy, 2) therapeutic decision-making, and 3) parent/child acceptability in children referred for evaluation of obstructive sleep apnea.
Eligibility
Inclusion Criteria3
- Male and female children age 5-12 years old inclusive
- Referred for diagnostic PSG at the Children's Hospital of Philadelphia (CHOP) Sleep Laboratory for evaluation of OSA as part of clinical care
- Parental/guardian permission (informed consent) and if appropriate, child assent.
Exclusion Criteria5
- Children without Down syndrome who have had a PSG within 3 years of enrollment
- Children with Down syndrome who have had a PSG within 1 year of enrollment.
- Children with a history of hypoventilation or hypoxemia or who require supplemental oxygen or positive airway pressure during sleep
- Children with a tracheostomy or tracheocutaneous fistula
- Children who live in a facility without their parent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Level II home sleep apnea testing evaluates for obstructive sleep apnea in the home environment with parental supervision.
Overnight sleep study in the sleep laboratory with continuous monitoring by clinical staff.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05382754